Abstract:Thousands of microorganisms reside in the human gut, and extensive research has demonstrated the crucial role of the gut microbiota in overall health and maintaining homeostasis. The disruption of microbial populations, known as dysbiosis, can impair the host's metabolism and contribute to the development of various diseases, including cardiovascular disease (CVD). Furthermore, a growing body of evidence indicates that metabolites produced by the gut microbiota play a significant role in the pathogenesis of cardiovascular disease. These bioactive metabolites, such as short-chain fatty acids (SCFAs), trimethylamine (TMA), trimethylamine N-oxide (TMAO), bile acids (BAs), and lipopolysaccharides (LPS), are implicated in conditions such as hypertension and atherosclerosis. These metabolites impact cardiovascular function through various pathways, such as altering the composition of the gut microbiota and activating specific signaling pathways. Targeting the gut microbiota and their metabolic pathways represents a promising approach for the prevention and treatment of cardiovascular diseases. Intervention strategies, such as probiotic drug delivery and fecal transplantation, can selectively modify the composition of the gut microbiota and enhance its beneficial metabolic functions, ultimately leading to improved cardiovascular outcomes. These interventions hold the potential to reshape the gut microbial community and restore its balance, thereby promoting cardiovascular health. Harnessing the potential of these microbial metabolites through targeted interventions offers a novel avenue for tackling cardiovascular health issues. This manuscript provides an in-depth review of the recent advances in gut microbiota research and its impact on cardiovascular health and offers a promising avenue for tackling cardiovascular health issues through gut microbiome-targeted therapies.

Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health

Role of short-chain fatty acids in host physiology

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation

Short chain fatty acids in human gut and metabolic health

Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism

Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension

Gut microbiota and health: connecting actors across the metabolic system

Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease

Short‐chain fatty acids: bridges between diet, gut microbiota, and health

The health benefits of dietary short-chain fatty acids in metabolic diseases

Gut macrobiotic and its metabolic pathways modulate cardiovascular disease

Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review

The role of short-chain fatty acids in health and disease

From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?

Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

The role of short chain fatty acids in appetite regulation and energy homeostasis

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease